Vanguard Personalized Indexing Management
PHXM

Vanguard Personalized Indexing Management’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio PHXM Stock Details PHXM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,427
Closed -$18.7K – 1562
2023
Q2 		$18.7K Hold
2,427
– – ﹤0.01% 1449
2023
Q1 		$23.8K Sell
2,427
-3,057
-56% -$23.6K ﹤0.01% 1439
2022
Q4 		$18.1K Sell
5,484
-500
-8% -$2.93K ﹤0.01% 1256
2022
Q3 		$33K Sell
5,984
-3,543
-37% -$35.1K ﹤0.01% 1203
2022
Q2 		$107K Buy
+9,527
New +$118K 0.01% 1196

Other funds holding PHXM

ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Personalized Indexing Management's PHXM Position: Q3 2023 in Review

Vanguard Personalized Indexing Management sold out of PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) in Q3 2023, closing a stake of 2,427 shares — an estimated $18.7K sold.

Vanguard Personalized Indexing Management first reported a position in PHXM in Q2 2022 and held it in 5 quarters. The position peaked at $107K in Q2 2022. 3 funds tracked by Wall St. Rank hold PHXM as of Q3 2023.

  • Vanguard Personalized Indexing Management reported no remaining PHAXIAM Therapeutics S.A.. American Depositary Shares position as of Q3 2023 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 2,427 PHAXIAM Therapeutics S.A.. American Depositary Shares shares in Q3 2023, an estimated $18.7K.
  • Vanguard Personalized Indexing Management first reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares in Q2 2022 and held it in 5 quarters.
  • Vanguard Personalized Indexing Management's PHAXIAM Therapeutics S.A.. American Depositary Shares position peaked at $107K in Q2 2022.
  • 3 funds tracked by Wall St. Rank held PHAXIAM Therapeutics S.A.. American Depositary Shares as of Q3 2023.

Based on Vanguard Personalized Indexing Management's 13F filing for Q3 2023, filed 8 Nov 2023.